Cargando…
miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
miRNAs have emerged as critical regulators of nearly all biologic processes and important therapeutic targets for numerous diseases. However, despite the tremendous progress that has been made in this field, many misconceptions remain among much of the broader scientific community about the manner i...
Autores principales: | Price, Nathan L, Goedeke, Leigh, Suárez, Yajaira, Fernández‐Hernando, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103095/ https://www.ncbi.nlm.nih.gov/pubmed/33938628 http://dx.doi.org/10.15252/emmm.202012606 |
Ejemplares similares
-
Uncovering the Specific Functions of miR-33 in Regulation of Feeding and Cardiometabolic Diseases Linked to Aging
por: Price, Nathan, et al.
Publicado: (2020) -
Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance
por: Price, Nathan L., et al.
Publicado: (2018) -
Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice
por: Goedeke, Leigh, et al.
Publicado: (2014) -
miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression
por: Benito-Vicente, Asier, et al.
Publicado: (2020) -
Identification of miR-148a as a novel regulator of cholesterol metabolism
por: Goedeke, Leigh, et al.
Publicado: (2015)